InvestorsHub Logo
Followers 5
Posts 785
Boards Moderated 0
Alias Born 05/13/2017

Re: None

Sunday, 09/22/2019 6:12:22 PM

Sunday, September 22, 2019 6:12:22 PM

Post# of 43747
Immunotherapies are already revolutionising treatment for quite a few cancer types, similarly it also helps to cure a patient with Head and neck cancer.

Doctors are working to learn more about head and neck cancer, ways to avert it, how to best treat it, and how to offer the best care to people diagnosed with this disease.

Even as per a new study, the estimated survival rate after 12 months for those that just received chemotherapy was 49.4 percent — in other words, just under half of those patients survived for a year. But the survival rate for patients who went for immunotherapy was dramatically higher: 69.2 percent.

https://health.economictimes.indiatimes.com/news/industry/immunotherapies-are-quickly-moving-from-research-labs-into-clinics-with-exciting-results-dr-vashishth-maniar/71240805
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News